<table id="i5d95d771-6b00-4f01-8e9e-74cb90bfe3ca" width="75%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col align="left" valign="top" width="25%"></col>
<col align="left" valign="top" width="75%"></col>
<thead>
<tr>
<th stylecode="Lrule">Interacting Drug</th>
<th stylecode="Lrule Rrule">Interaction</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Multivalent cation-containing products including antacids, metal cations or didanosine</td>
<td stylecode="Rrule">Absorption of levofloxacin is decreased when the tablet or oral solution formulation is taken within 2 hours of these products. Do not co-administer the intravenous formulation in the same IV line with a multivalent cation, e.g., magnesium (<linkhtml href="#S2.4">2.4</linkhtml>, <linkhtml href="#S7.1">7.1</linkhtml>)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Warfarin</td>
<td stylecode="Rrule">Effect may be enhanced. Monitor prothrombin time, INR, watch for bleeding (<linkhtml href="#S7.2">7.2</linkhtml>)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Antidiabetic agents</td>
<td stylecode="Rrule">Carefully monitor blood glucose (<linkhtml href="#S5.11">5.11</linkhtml>, <linkhtml href="#S7.3">7.3</linkhtml>)</td>
</tr>
</tbody>
</table>